Sign in
4

Changes in Ownership

Enliven Therapeutics, Inc. Filed Acc 0001415889-24-008883

Director sold 1,270 shares at $14.50 ($18,419)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Heyman Richard A. · Director

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2024-03-19 Sale : show line 1 in the form 10b5-1 −1,270 $14.50 $18,419 143,470 D
Open-market sales · 1,270 sh · avg $14.50 · $18,419
Loading xslF345X05/form4-03212024_100359.xml…